Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verweij

Showing results (91-100 of 344) with videos related to

Pageof 35
Sort By:
Scandinavian Journal of Work, Environment & Health|January 5, 2013
Long-term effects of an occupational health guideline on employees' body weight-related outcomes, cardiovascular disease risk factors, and quality of life: results from a randomized controlled trialLisanne M Verweij, Karin I Proper, Andre N H Weel, et al.
Occupational and Environmental Medicine|March 3, 2012
The application of an occupational health guideline reduces sedentary behaviour and increases fruit intake at work: results from an RCTLisanne M Verweij, Karin I Proper, Andre N H Weel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 19, 2015
Non-surgical complications after laparoscopic and open surgery for colorectal cancer - A systematic review of randomised controlled trialsA H W Schiphorst, N M Verweij, A Pronk, et al.
Infection and Immunity|June 1, 1983
Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytesF Namavar, A M Verweij, M Bal, et al.
The Journal of Infectious Diseases|September 1, 1986
Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5B J Appelmelk, A M Verweij-van Vught, J J Maaskant, et al.
Acta Clinica Belgica|November 30, 2012
Hazelnut allergy: a multi-faced condition with demographic and geographic characteristicsD G Ebo, M M Verweij, V Sabato, et al.
Human Reproduction (Oxford, England)|June 7, 2014
Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolFrank J Broekmans, Pierre J M Verweij, Marinus J C Eijkemans, et al.
Health Policy (Amsterdam, Netherlands)|July 27, 2021
Facilitators and barriers for implementing patient-reported outcome measures in clinical care: An academic center's initial experienceMarzyeh Amini, Arvind Oemrawsingh, Lisanne M Verweij, et al.
Plos One|March 8, 2016
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist ProtocolGeorg Griesinger, Pierre J M Verweij, Davis Gates, et al.
International Journal of Technology Assessment in Health Care|April 17, 2018
EXPLORING MEDICAL DEVICES: THE USE OF RISK ASSESSMENT TOOLS AND THEIR LINK WITH TRAINING IN HOSPITALSPetra J Porte, Lisanne M Verweij, Martine C de Bruijne, et al.
Pageof 35

Showing results (91-100 of 344) with videos related to

Sort By:
Pageof 35
Scandinavian Journal of Work, Environment & Health|January 5, 2013
Long-term effects of an occupational health guideline on employees' body weight-related outcomes, cardiovascular disease risk factors, and quality of life: results from a randomized controlled trialLisanne M Verweij, Karin I Proper, Andre N H Weel, et al.
Occupational and Environmental Medicine|March 3, 2012
The application of an occupational health guideline reduces sedentary behaviour and increases fruit intake at work: results from an RCTLisanne M Verweij, Karin I Proper, Andre N H Weel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 19, 2015
Non-surgical complications after laparoscopic and open surgery for colorectal cancer - A systematic review of randomised controlled trialsA H W Schiphorst, N M Verweij, A Pronk, et al.
Infection and Immunity|June 1, 1983
Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytesF Namavar, A M Verweij, M Bal, et al.
The Journal of Infectious Diseases|September 1, 1986
Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5B J Appelmelk, A M Verweij-van Vught, J J Maaskant, et al.
Acta Clinica Belgica|November 30, 2012
Hazelnut allergy: a multi-faced condition with demographic and geographic characteristicsD G Ebo, M M Verweij, V Sabato, et al.
Human Reproduction (Oxford, England)|June 7, 2014
Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolFrank J Broekmans, Pierre J M Verweij, Marinus J C Eijkemans, et al.
Health Policy (Amsterdam, Netherlands)|July 27, 2021
Facilitators and barriers for implementing patient-reported outcome measures in clinical care: An academic center's initial experienceMarzyeh Amini, Arvind Oemrawsingh, Lisanne M Verweij, et al.
Plos One|March 8, 2016
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist ProtocolGeorg Griesinger, Pierre J M Verweij, Davis Gates, et al.
International Journal of Technology Assessment in Health Care|April 17, 2018
EXPLORING MEDICAL DEVICES: THE USE OF RISK ASSESSMENT TOOLS AND THEIR LINK WITH TRAINING IN HOSPITALSPetra J Porte, Lisanne M Verweij, Martine C de Bruijne, et al.
Pageof 35